FDC Limited (BOM:531599)
India · Delayed Price · Currency is INR 388.05
-2.00 (-0.51%)
At close: Feb 12, 2026
FDC Limited Market Cap
FDC Limited has a market cap or net worth of 63.18 billion as of February 13, 2026. Its market cap has decreased by -17.71% in one year.
Market Cap
63.18B
Enterprise Value
59.13B
Revenue
20.78B
Ranking
n/a
PE Ratio
29.18
Stock Price
388.05
Market Cap Chart
Since May 30, 2002, FDC Limited's market cap has increased from 2.73B to 63.18B, an increase of 2,216.32%. That is a compound annual growth rate of 14.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 63.18B | -8.33% |
| Dec 31, 2025 | 68.92B | -15.14% |
| Dec 31, 2024 | 81.22B | 25.96% |
| Dec 29, 2023 | 64.48B | 43.15% |
| Dec 30, 2022 | 45.04B | -12.27% |
| Dec 31, 2021 | 51.34B | -8.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 148.25B |
| Granules India | 140.92B |
| Caplin Point Laboratories | 131.67B |
| Rubicon Research | 130.24B |
| CORONA Remedies | 99.91B |
| Sanofi India | 94.31B |
| Procter & Gamble Health | 91.46B |
| Viyash Scientific | 89.40B |